Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
24.16
+0.71 (3.03%)
At close: Apr 28, 2026, 4:00 PM EDT
24.30
+0.14 (0.58%)
After-hours: Apr 28, 2026, 5:20 PM EDT
Eton Pharmaceuticals Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Eton Pharmaceuticals stock have an average target of 39.33, with a low estimate of 31 and a high estimate of 52. The average target predicts an increase of 62.79% from the current stock price of 24.16.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 20, 2026.
Analyst Ratings
The average analyst rating for Eton Pharmaceuticals stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $26 → $31 | Strong Buy | Maintains | $26 → $31 | +28.31% | Mar 20, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $37 → $52 | Strong Buy | Maintains | $37 → $52 | +115.23% | Mar 20, 2026 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $30 → $35 | Strong Buy | Maintains | $30 → $35 | +44.87% | Mar 20, 2026 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $29 → $30 | Strong Buy | Maintains | $29 → $30 | +24.17% | Mar 3, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $35 → $37 | Strong Buy | Maintains | $35 → $37 | +53.15% | Mar 2, 2026 |
Financial Forecast
Revenue This Year
112.65M
from 79.95M
Increased by 40.90%
Revenue Next Year
165.85M
from 112.65M
Increased by 47.23%
EPS This Year
0.75
from -0.17
EPS Next Year
1.68
from 0.75
Increased by 122.52%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 116.4M | 185.3M | ||||||
| Avg | 112.7M | 165.9M | ||||||
| Low | 107.6M | 148.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 45.6% | 64.5% | ||||||
| Avg | 40.9% | 47.2% | ||||||
| Low | 34.6% | 31.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.10 | 2.22 | |
| Avg | 0.75 | 1.68 | |
| Low | 0.56 | 1.26 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | 193.5% | |
| Avg | - | 122.5% | |
| Low | - | 67.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.